Group 1 - The company held its fourth board meeting on February 6, 2026, with all seven directors present, and the meeting complied with relevant laws and regulations [2][4] - The board approved several key proposals, including the application for a comprehensive credit limit and guarantees for subsidiaries, which is deemed beneficial for financing needs [2][19] - The company plans to apply for a total credit limit of up to RMB 1.5 billion for its subsidiaries, with a maximum guarantee amount of RMB 500 million, which represents 58.84% of the company's latest audited net assets [20][30] Group 2 - The board approved the proposal to conduct financial derivatives business for 2026, with a total amount not exceeding RMB 400 million, primarily for hedging purposes [6][32] - The financial derivatives will include forward foreign exchange contracts, foreign exchange options, and interest rate swaps, aimed at managing foreign exchange risks [34][35] - The company will seek shareholder approval for these activities, which are not considered related party transactions [33][37] Group 3 - The board also approved the proposal to conduct asset pool business, allowing for a total amount not exceeding RMB 400 million, which aims to enhance liquidity and optimize financial structure [12][48] - The asset pool business will involve various financial assets and will be managed in collaboration with reputable commercial banks [49][50] - The company intends to use the asset pool to improve the efficiency of financial asset management and reduce capital occupation [53][54]

Core Viewpoint - The company plans to engage in financial derivatives trading to mitigate foreign exchange and interest rate risks for the year 2026 [1] Group 1: Financial Derivatives Trading - The company and its subsidiaries intend to conduct financial derivatives trading, including forward foreign exchange contracts and foreign exchange swaps [1] - The maximum margin and premium to be utilized for these transactions is set at 55 million yuan, with the highest contract value held on any trading day not exceeding 1.5 billion yuan [1] - The validity period for the usage of these trading limits is 12 months from the date of approval by the board of directors [1] Group 2: Risk Management - The company has analyzed market and liquidity risks associated with the trading activities and has established corresponding control measures [1] - Transactions will be conducted with qualified financial institutions, using the company's own funds [1]

Core Viewpoint - Rongjie Health Technology Co., Ltd. plans to engage in financial derivatives trading to mitigate foreign exchange risk associated with its export business, primarily settled in USD [1][2]. Summary by Sections Trading Overview - The company aims to conduct financial derivatives trading to hedge against foreign exchange fluctuations and reduce financial costs, focusing on non-speculative operations [1]. - The trading will involve currencies aligned with the company's primary settlement currency, including forward foreign exchange, foreign exchange swaps, currency swaps, foreign exchange options, and other financial derivatives [1]. - The trading limit is set at a maximum of RMB 100 million (or equivalent foreign currency), valid for 12 months from board approval, and can be reused [1]. Approval Process - The proposal for financial derivatives trading was approved by the company's board of directors on August 25, 2025, and does not require shareholder meeting approval [2]. Risk Analysis - The company acknowledges potential risks, including foreign exchange volatility, internal control weaknesses, liquidity issues, and legal risks associated with changes in laws or counterparty defaults [2]. - To mitigate these risks, the company has established a management system for financial derivatives trading, ensuring careful contract review and adherence to risk management protocols [2]. Impact on the Company - Engaging in financial derivatives trading is expected to help the company avoid foreign exchange market risks, lower financial costs, and enhance foreign exchange gains without adversely affecting its financial and operational status [3]. - The company will account for these transactions according to relevant accounting standards, with specific outcomes subject to audit [3].